Phase II clinical trial with pegylated liposomal doxorubicin (CAELYX/DOXIL) and quality of life evaluation (EORTC QLQ-C30) in adult patients with advanced soft tissue sarcomas: a study of the Spanish Group for Research in Sarcoma (GEIS)
| Autor: | Poveda A (AUTHOR), López-Pousa A (AUTHOR), Martín J (AUTHOR), Del Muro JG (AUTHOR), Bernabé R (AUTHOR), Casado A (AUTHOR), Balaña C (AUTHOR), Sanmartín O (AUTHOR), Menéndez MD (AUTHOR), Escudero P (AUTHOR), Cruz J (AUTHOR), Belyakova E (AUTHOR), Menéndez D (AUTHOR), Buesa JM (AUTHOR), Spanish Group for Research in Sarcomas (GEIS) (CORPORATE AUTHOR) |
|---|---|
| Zdroj: | Sarcoma. Sep-Dec2005, Vol. 9 Issue 3/4, p127-132. 6p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|